JDRF Blog

Latest in Research

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia

    September 11, 2019

    “The approval of the GVOKE HypoPenTM is an important step forward for people with diabetes. Severe hypoglycemia is a terrifying and dangerous...

  • Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

    September 4, 2019

    In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

  • FDA Approves the First Low Blood Sugar Treatment WITHOUT an Injection

    July 25, 2019

    Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone takes too...

  • JDRF Top Advances Over the Past Year

    July 1, 2019

    Thanks to the efforts of our donors and volunteers, we have made a series of top advances in our fight to cure...

  • At ADA, JDRF-Funded Research Takes Center Stage

    June 17, 2019

    JDRF was there when the top type 1 diabetes (T1D) experts from all over the world convened this month at the American...

  • Two T1D Technology Leaders Partnering to Drive Innovation and Choice

    June 11, 2019

    Two leading innovators in the T1D space have announced a collaborative partnership aimed at enabling those with T1D to select favorite devices,...

  • A New AP System by Tandem Shows Key Time-in-Range Benefits

    June 10, 2019

    A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with type 1...

  • JDRF Heads to ADA’s 79th Scientific Sessions

    June 6, 2019

    The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and healthcare professionals...